Literature DB >> 17242259

Contrast harmonic sonography-guided radiofrequency ablation therapy versus B-mode sonography in hepatocellular carcinoma: prospective randomized controlled trial.

Yasunori Minami1, Masatoshi Kudo, Hobyung Chung, Toshihiko Kawasaki, Yukinobu Yagyu, Taro Shimono, Hitoshi Shiozaki.   

Abstract

OBJECTIVE: The purpose of this study was to evaluate the effectiveness of contrast harmonic sonographic guidance in radiofrequency ablation of locally progressive hepatocellular carcinoma poorly depicted with B-mode sonography. SUBJECTS AND METHODS: A series of 40 patients with hepatocellular carcinoma with local tumor progression poorly depicted with B-mode sonography were randomly treated with radiofrequency ablation guided by either contrast harmonic sonography (n = 20) or conventional B-mode sonography (n = 20). Unpaired Student's t tests were performed to compare numbers of treatment sessions.
RESULTS: Treatment analysis showed that the complete ablation rate after a single treatment session was significantly higher in the contrast harmonic sonography group than in the B-mode sonography group (94.7% vs 65.0%; p = 0.043) and that the number of treatment sessions was significantly lower in the contrast harmonic sonography group (mean, 1.1 +/- 0.2 vs 1.4 +/- 0.6; p =0.037).
CONCLUSION: Contrast harmonic sonography-guided radiofrequency ablation is an efficient technique for guiding further ablation of local tumor progression not clearly demarcated with B-mode sonography.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17242259     DOI: 10.2214/AJR.05.1286

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  16 in total

1.  Usefulness of Sonazoid contrast-enhanced ultrasonography for hepatocellular carcinoma: comparison with pathological diagnosis and superparamagnetic iron oxide magnetic resonance images.

Authors:  Keiko Korenaga; Masaaki Korenaga; Matakazu Furukawa; Takahiro Yamasaki; Isao Sakaida
Journal:  J Gastroenterol       Date:  2009-04-23       Impact factor: 7.527

2.  In vivo guidance and assessment of liver radio-frequency ablation with acoustic radiation force elastography.

Authors:  Brian J Fahey; Rendon C Nelson; Stephen J Hsu; David P Bradway; Douglas M Dumont; Gregg E Trahey
Journal:  Ultrasound Med Biol       Date:  2008-05-09       Impact factor: 2.998

3.  Utility of contrast-enhanced ultrasound with perflubutane for diagnosing the macroscopic type of small nodular hepatocellular carcinomas.

Authors:  Toshifumi Tada; Takashi Kumada; Hidenori Toyoda; Takanori Ito; Yasuhiro Sone; Yuji Kaneoka; Atsuyuki Maeda; Seiji Okuda; Katsuhiko Otobe; Kenichi Takahashi
Journal:  Eur Radiol       Date:  2014-06-22       Impact factor: 5.315

4.  Breakthrough Imaging in Hepatocellular Carcinoma.

Authors:  M Kudo
Journal:  Liver Cancer       Date:  2015-12-18       Impact factor: 11.740

5.  Defect Reperfusion Imaging with Sonazoid®: A Breakthrough in Hepatocellular Carcinoma.

Authors:  M Kudo
Journal:  Liver Cancer       Date:  2015-12-15       Impact factor: 11.740

6.  Contrast-enhanced ultrasound to ultrasound fusion during microwave ablation: feasibility study in a perfused porcine liver model.

Authors:  Wayne Monsky; Christina Keravnou; Michalakis Averkiou
Journal:  J Ultrasound       Date:  2019-02-27

7.  Radiofrequency ablation of hepatocellular carcinoma: Current status.

Authors:  Yasunori Minami; Masatoshi Kudo
Journal:  World J Radiol       Date:  2010-11-28

8.  Hepatic malignancies: Correlation between sonographic findings and pathological features.

Authors:  Yasunori Minami; Masatoshi Kudo
Journal:  World J Radiol       Date:  2010-07-28

9.  Contrast enhanced ultrasound of hepatocellular carcinoma.

Authors:  Kazushi Numata; Wen Luo; Manabu Morimoto; Masaaki Kondo; Yosuke Kunishi; Tomohiko Sasaki; Akito Nozaki; Katsuaki Tanaka
Journal:  World J Radiol       Date:  2010-02-28

10.  High-intensity focused ultrasound ablation for the treatment of colorectal liver metastases during an open procedure: study on the pig.

Authors:  Hubert Parmentier; Parmentier Hubert; David Melodelima; Melodelima David; Apoutou N'Djin; N'Djin Apoutou; Sabrina Chesnais; Chesnais Sabrina; Jean Yves Chapelon; Chapelon Jean Yves; Michel Rivoire; Rivoire Michel
Journal:  Ann Surg       Date:  2009-01       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.